A once-a-day, extended-release formulation of lamothgine, exhibiting a significantlysimilar release rate throughout the Gl tract irrespective of the pH of the environment,is provided. The formulation comprises lamothgine, an organic acid, a releaseenhancing polymer and a release controlling polymer. The use of the formulationfor the treatment of the neurological disorders is also disclosed.
